EcoDrugPlus

Erb-B2 Receptor Tyrosine Kinase 3b

Ensembl ID : ENSOTSG00005039650
Gene Symbol: ERBB3B
1 Cross references
199 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3b

Ensembl ID : ENSOTSG00005034827
Gene Symbol: ERBB3B
1 Cross references
199 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSOTSG00005013479
Gene Symbol: ERBB4
1 Cross references
9 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSOTSG00005009631
Gene Symbol: ERBB4
1 Cross references
8 Possible Orthologues:

Estrogen Receptor

Ensembl ID : ENSOTSG00005034433
Gene Symbol: LOC112217720
3 Cross references
206 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSOTSG00005028906
Gene Symbol: ESR1
1 Cross references
206 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSOTSG00005030805
Gene Symbol: ESR1
1 Cross references
206 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSOTSG00005040362
Gene Symbol: ESR1
1 Cross references
206 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSOTSG00005027786
Gene Symbol: ESR1
1 Cross references
206 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSOTSG00005000418
Gene Symbol: LOC112250425
3 Cross references
198 Possible Orthologues:

Estrogen Receptor Beta-Like

Ensembl ID : ENSOTSG00005026502
Gene Symbol: LOC112261698
3 Cross references
203 Possible Orthologues:

Exportin 1

Ensembl ID : ENSOTSG00005016459
Gene Symbol: XPO1
1 Cross references
218 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).